Kudos and thanks to Mary Oris!

As the Duke CFAR Administrator, Mary does so much behind the scenes to support the success of our center. We are especially grateful to her for her tireless efforts in preparing and submitting the CFAR renewal. Thank you, Mary!!

News from the CFAR

Duke CFAR researchers highlight the existential threat of climate change

"The year is barely halfway over and extreme weather events have dominated headlines around the globe. Frightening floods pestered Pakistan; terrible tornados terrorized the Midwest United States. For 421 straight days, an unprecedented heat wave scorched the North Atlantic Ocean. While writing this piece, Hurricane Beryl paved a path of destruction from the Caribbean to Canada.

Climate change is an existential crisis–one that not only threatens weather patterns and biodiversity, but marginalized communities with limited access to quality healthcare. Here are three ways climate change is endangering the HIV/AIDS fight, in particular." Read more from "Warming Planet Threatens to Chill AIDS Fight".

A recent article in Forbes by President and COO of (RED), Jennifer Lotito, highlights the threats that climate change poses specifically to our efforts to fight HIV and AIDS worldwide.

Duke's Climate Commitment is a university-wide, impact-oriented initiative to address the climate crisis by creating sustainable and equitable solutions that place society on the path toward a resilient, flourishing, carbon-neutral world. 

The Duke CFAR has been leading discussions to shed light on the disproportionate impacts of climate change on people living with HIV, nations in the Global South, and individuals with minoritized identifies. CFAR investigators have recently come together with others from across Duke (including the Nicholas School of the Environment, Pratt School of Engineering, and Duke Global Health Institute) and in the community (including collaborating with Dr. Chris Hawn of the North Carolina Environmental Justice Network), to publish articles and commentaries shedding light on this important and dire topic.

Women plant mangrove saplings along the riverbanks of the Matla river in Sundarbans, India as part of efforts to combat the impacts of climate change. (Avijit Ghosh / Climate Visuals CC BY-NC-ND 4.0)

Dr. Keith Reeves helped lead the coordinated efforts of two commentaries. As he shares, "Climate change is one of the greatest threats to overall human health, but current models don’t always evaluate the intersection with structural inequity, social determinants of health, nor do they consider individual health at the cellular and molecular level, such as immune health resilience.   Recent evaluations by multiple members of the Duke CFAR as well as CHSI and DGHI are leading efforts to understand the disparate impacts climate change may have on persons living with HIV, since the time is now to consider equitable interventions and solutions for both preserving health and access to care."

Intersectional climate justice, health equity, and HIV.

Wilson SM, Woolley G, Hawn C, Hoffman K, Jones AD, Chan C, Mudrak SV, Qureshi MU, Ward A, Knippler ET, Okeke NL, Corneli A, Tomaras GD, Reeves RK.

Lancet HIV. 2024 May;11(5):e280-e281. doi: 10.1016/S2352-3018(24)00062-6.

Current models of climate change and HIV acknowledge the impact of social determinants of health (eg, geographic location, socioeconomic status) but do not include theorised causal pathways linked to systems-level influences. Nations in the Global South (eg, sub-Saharan African, South American, and southeast Asian countries) and individuals with minoritised identities face a disproportionate burden of the HIV syndemic (ie, the way that HIV interacts with other infectious diseases and health concerns to yield increased health burden). These populations also face inequity related to current and future climate change impacts. We argue that this is not a coincidence. In this Comment, we expand on one current model of climate change and HIV by including the legacy of racist colonial expansion and ongoing systemic inequity.

Read the full commentary. 

The Climate Change Burden on Immune Health: Are Persons Living with HIV More at Risk?

Woolley G, Kroll K, Hoffman K, Ward A, Corneli A, Mudrak SV, Qureshi MU, Okeke NL, Chan C, Jones AD, Tomaras GD, Reeves RK.

AIDS Res Hum Retroviruses. 2024 May 27. doi: 10.1089/AID.2024.0050.

Climate change poses one of the most significant modern threats to overall human health, especially for vulnerable populations including persons living with HIV (PLWH). In this perspective, we specifically explore the concept of immune resilience in human health and how climate change phenomena - including extreme weather events, food insecurity, pollution, and emerging diseases - may exacerbate immune dysfunction and comorbidities faced by PLWH and hinder access to HIV treatment and prevention services. Multidisciplinary, collaborative efforts are urgently needed to quantify these impacts, develop mitigation strategies, and strengthen policies and funding to bolster immune resilience for PLWH in the face of accelerating climate change.

Read the full article.

Climate change poses dire health and human rights risks.

Chris Beyrer.

360info. 2024 April 24. doi: 10.54377/2eff-10fa

Climate change has not traditionally been seen as a health and human rights concern — but that may be changing following recent high-profile court cases.

On April 9 the European Court of Human Rights ruled in favour of a group of elderly Swiss women who claimed the government’s inadequate efforts to combat climate change put them at risk of dying during heatwaves. And in India, the Supreme Court on April 6 recognised a right against the adverse effects of climate change as a distinct fundamental right in the Constitution. In that judgement, one of the judges said the rights to life and equality couldn’t be fully realised without a clean, stable environment. The court also highlighted the connection between climate change and the right to health.

The World Health Organization has declared climate change to be the greatest threat to health that humanity faces.

Since climate change affects so many aspects of our lives, its effects on health and health care are complex, multiple, and highly variable across geographies, ecozones and development levels. There are direct impacts on our bodies and communities, such as have emerged with extreme heat, droughts, floods, fires and other climate change-driven catastrophic events.

There also are more complex and indirect impacts, such as increasing food insecurity, the rising threat of infectious diseases, increased exposure to water and air pollutants, the health impacts of forced mobility and migration, and the mental health and social impacts of the climate crisis that affect us on our deepest levels.

Yet climate change has not traditionally been seen as a health and human rights concern — a reality which, arguably, needs to change.

In a report published last month in The Lancet, ‘Under threat: The International AIDS Society-Lancet Commission on Health and Human Rights’ we suggested several pathways through which climate change bears on the right to health.

Read the full article.

What we're reading (and watching)

Heart of the Matter: People living with HIV are crucial to clinical trials related to the virus - POZ Magazine

In this feature, Alicia Diggs, MPH speaks about the importance of representative participation in clinical trials, the history of harm from the medical and research systems, and the duty of clinicians and researchers when conducting trials. Alicia is the UNC CFAR’s Office of Community Engagement Manager.



Dean Mary Klotman's Conversation with Dr. Anthony Fauci

During his recent visit to Duke University, Dr. Anthony Fauci sat down with School of Medicine Dean Mary Klotman, MD, to discuss his long and storied career in public health, the history of HIV/AIDS and the progress being made to develop a vaccine to prevent it.

A Decade of Excellence: Duke School of Nursing's HIV Specialty Certificate

As the Duke School of Nursing celebrates the 10-year anniversary of its HIV Specialty Certificate, specialty director Kara McGee reflects on the profound impact the program has had.

DGHI Feature - Understanding the Link Between HIV and Heart Disease

As Gerald S. Bloomfield, M.D., saw heart patients in Kenya over the past decade, he knew that cardiovascular disease was on the rise in the country. But he also noticed another trend. Many of the patients who came in with heart issues also had HIV. As people with HIV live longer, doctors are confronting a new challenge: how to keep their hearts healthy into old age.

Viewpoint: Is HIV epidemic control by 2030 realistic?

Chris Beyrer, Georgia Tomaras, Huub Gelderblom, Glenda Gray, Holly Janes, Linda-Gail Bekker, Gregorio Millett , Giuseppe Pantaleo, Susan Buchbinder, Lawrence Corey 

Lancet HIV. 2024 Jul;11(7):e489-e494. doi: 10.1016/S2352-3018(24)00098-5.

Rates of new HIV acquisition remain unacceptably high in most populations in low-income, middle-income, and high-income settings despite advances in treatment and prevention strategies. Although biomedical advances in primary prevention of new infections exist, systematic scale-up of these interventions has not occurred at the pace required to end AIDS by 2030. Low population coverage, adherence to oral pre-exposure prophylaxis in settings with high rates of HIV acquisition, and the fact that a significant proportion of new HIV infections occurs in populations not identified as high risk and are hence not targeted for prevention approaches impedes current prevention strategies. Although long-acting injectables and monoclonal antibodies are promising approaches to help reduce incidence, high cost and the need for high coverage rates mean that a vaccine or vaccine-like intervention still remains the most likely scenario to produce a population-level impact on HIV incidence, especially in countries with generalised epidemics. Current global efforts are not sufficient to meet 2030 HIV epidemic goals; acknowledgment of this issue is required to ensure persistent advocacy for population-based control of the ongoing HIV pandemic.

HANC Webinar recording - Community & Stakeholder Input to Inform the Future of HIV Research

Every seven years, the NIH engages in a process that will help determine the focus and priorities of its global HIV clinical trials research networks. HANC hosted conversations with Dr. Carl Dieffenbach, Director of the Division of AIDS at the NIH's National Institute of Allergy and Infectious Diseases (NIAID) about the future of global HIV research. The robust discussion covered topics ranging from structural issues, HIV cure-related research, HIV prevention, aging on ART, funding, the future of bnABs, and participant inclusion and representation.

NIAD HIV Language Guide

NIAID is making every effort to eliminate the use of stigmatizing terminology and advance the use of person-first, inclusive, and respectful language. This updated HIV Language Guide (May 2024) is an important step toward that end. This resource is applicable to all communications, including but not limited to grant applications, contracts, publications, presentations, abstracts, and press materials. 

Duke Happy Hour Mixer at AIDS 2024

Thursday, July 25, 2024 | 5:30-7 pm CET | Novotel Hotel - Munich, Germany

The Duke CFAR will sponsor a happy hour at the AIDS 2024 Conference in Munich, Germany. Please RSVP and share your accepted abstract/presentation details with the CFAR.

Please send details of your presentations and any photos you take of Duke CFAR at AIDS 2024 to Lizzy Knippler for inclusion in an upcoming newsletter!

RSVP for the event. While you're at the conference, check out...

Language (Mis)use in HIV Research Communications

Tuesday, July 23, 2024| 2 pm CET | Munich, Germany (AIDS 2024)

Wednesday, September 18, 2024 | 11am ET | Zoom

Are you ready to immerse yourself in a vibrant fusion of science and community engagement? Look no further! The DZIF workshop is coming to the AIDS 2024 Global Village, and we want YOU to be a part of it.

Part 1: Bridging Communities: Enhancing Engagement through Language in HIV Research

📅 When: July 23, 2024, 2 PM CEST

📍 Where: Messe München, Am Messesee 2, 81829. München, Germany

Hall A2, Trade Fair Center

What to Expect:

✨ Connect with diverse communities from around the globe.

✨ Participate in poster discussions and questionnaires on language (mis)use in HIV research communications.

✨ Share your opinions and experiences.

✨ Explore DZIF-related HIV research activities.

✨ Witness how science translates into community action and interventions.

Part 2: Reducing HIV Stigma through Appropriate Language in Scientific Communications

Can't make it to AIDS 2024 Global Village? No worries! Join us for Part 2 of the DZIF workshop in an online seminar.

📅 When: Sept 18th, 11 AM ET

🖥️ Where: Register for the Zoom Link

What's in Store:

🎤 Presentations by HOPE Community members on language use and HIV stigma.

📊 Summary of results from Part 1 of the workshop.

🗣️ Panel discussion on the importance of language choice in research communications.

🔍 Informed guidance on engaging with communities through language in research.

Save the Date - Transgender Health Working Group Panel Discussion

Thursday, September 5, 2024 | 3:30-5 pm ET | Zoom

Title: Intersection of Transgender Research & Policy

Date & Time: Sept. 5th, 3:30pm - 5pm

The aim of this panel/discussion is to address both how to use research to inform policy, as well as how to conduct research with trans communities in challenging policy environments.

28th West Coast Retrovirus Meeting

October 3-5, 2024 | Palm Springs, CA

Please join us this fall for the 28th West Coast Retrovirus Meeting in Palm Springs, California! This workshop-style meeting recognizes historical achievements and milestones in the field of retrovirology, while providing a forum to discuss new and unpublished information across relevant areas including antiviral drug development, viral evolution, structural virology and virus-host interactions.

Invited speakers include the Duke CFAR's very own Priyamvada Acharya.

To attend the meeting, please register by August 31, 2024. After August 31, we will continue to accept registrations until the meeting is fully subscribed.

The abstract deadline is August 1 for oral presentations, and September 1 for poster presentations or no preference. Please indicate if the abstract is for a short oral presentation or poster presentation, or no preference. Notification of whether presentations will be talks or posters will be sent out in mid-September.

Learn more and register.

Inter-CFAR Faith & Spirituality Research Collaborative National Meeting

October 21-22, 2024 | Nashville, TN

Registration is open for a national meeting focused on exploring the opportunities in research at the intersection of Faith, Spirituality, and HIV to foster new collaborations toward ending the HIV epidemic. Bringing together those who have experience with faith communities and have interest in becoming engaged with implementation science research, and investigators involved in HIV implementation science. Please register by September 10.

October 21-22, 2024

The Cal Turner Family Center at Meharry Medical College

Wayne Riley Auditorium

1011 21st Ave N, Nashville, TN 37208

Register for the meeting.

Registration open for the Annual Mentoring the Mentors Workshop for HIV Researchers

October 22-23, 2024 | San Francisco, CA

Investigators interested in attending the workshop are asked to complete the Registration Form. The application process for participation in the workshop will close on Friday, August 30, 2024 (scholarship deadline August 21, 2024). Registrants accepted to participate in the workshop will be notified by email the week of September 9, 2024.

The two-day workshop is an intensive and interactive meeting designed to provide faculty in HIV research with the tools for more effective mentoring, especially of mentees of diversity (defined mainly as those from underrepresented racial/ethnic minorities). The workshops discusses barriers related to being an early career investigator of diversity (e.g. microaggressions, unconscious bias), and features didactic and interactive sessions on practical tips for mentoring, including sessions on intersectionality in mentoring, funding sources for mentoring efforts, time management, leadership styles, manuscript writing, grant writing, individual development plans, teaching work-life balance to mentees, alternative funding strategies, forming teams, etc. Descriptions and findings from the 1st workshop, the 2nd workshop and the 3^rd workshop are found here.

Scholarships

We anticipate that we will award a number of travel and lodging scholarships to support airfare/hotel for selected applicants. Potential participants interested in applying for the travel scholarship must have involvement in HIV research. Scholarship priority will be given to the following groups:

• Mentors, particularly ESIs, from backgrounds underrepresented in the U.S. Biomedical, Clinical, Behavioral, and Social Sciences Research Enterprise as defined by NIH NOT-OD-20-031, especially members of the Inter-CFAR URM Working Group attending the 10/24-25 meeting
• Current CDEIPI or other HIV research pipeline program mentors
• Mentors who have no other ways of funding their attendanc

Please register for the scholarship by submitting a recent CV and a cover letter describing your interest in the workshop, your involvement in mentoring, and (if applicable), a statement of your need for the scholarship in light of other resources available to you (e.g., CFAR support, department/divisional funds, currently existing grant/discretionary/CE funding) with your Registration Form by August 21, 2024. 

Inter-CFAR URM in HIV Research Meeting

We are also hosting the 3rd annual Inter-CFAR Meeting for CFAR-affiliated Underrepresented Minorities in HIV Research on the Thursday and Friday of that week (October 24th and 25th). This facilitated strategy meeting will work to build off findings from the first and second Inter-CFAR URM meetings held in 2022 and 2023 and help build new research collaborations in line with key HIV research needs and gaps. If you are in an URM group and working in HIV research either at a CFAR or close to a CFAR, please do consider joining our group. Prior attendees are encouraged to come as we the work will be iterative from prior workshops. Please contact Lauren Sterling (lauren.sterling@ucsf.edu) and Elizabeth Nguyen (Elizabeth.Nguyen4@ucsf.edu) for more information on the Inter-CFAR URM meeting.

For any questions, please email the coordinator of this event, Joseph Watabe, Division of HIV, ID and Global Medicine (Joseph.watabe@ucsf.edu). 

Learn more and apply.

Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy.

Stout JA, Allamong M, Hung F, Link K, Chan C, Muiruri C, Sauceda J, McKellar MS.

AIDS Behav. 2024 Jul 1. doi: 10.1007/s10461-024-04423-x.

Psychological processes and alcohol reduction in patients with chronic hepatitis C: Results from the HepART trial.

Evon DM, Yao J, Zimmer C, Muir AJ, Hendershot CS, Proeschold-Bell RJ.

Alcohol Clin Exp Res (Hoboken). 2024 Jun 25. doi: 10.1111/acer.15400.

Cyclophilin A Facilitates HIV-1 DNA Integration.

Padron A, Dwivedi R, Chakraborty R, Prakash P, Kim K, Shi J, Ahn J, Pandhare J, Luban J, Aiken C, Balasubramaniam M, Dash C.

bioRxiv [Preprint]. 2024 Jun 17:2024.06.15.599180. doi: 10.1101/2024.06.15.599180.

Three prime repair exonuclease 1 preferentially degrades the integration-incompetent HIV-1 DNA through favorable kinetics, thermodynamic, structural, and conformational properties.

Prakash P, Khodke P, Balasubramaniam M, Davids BO, Hollis T, Davis J, Kumbhar B, Dash C.

J Biol Chem. 2024 Jun 3;300(7):107438. doi: 10.1016/j.jbc.2024.107438.

Specialty Care Referral for Underrepresented Minorities Living with HIV in the United States: Experiences, Barriers, and Facilitators.

Muiruri C, Dombeck C, Swezey T, Gonzales S, Lima M, Gray S, Vicini J, Pettit AC, Longenecker CT, Meissner EG, Okeke NL, Bloomfield GS, Corneli A.

AIDS Patient Care STDS. 2024 Jun;38(6):259-266. doi: 10.1089/apc.2024.0066.

The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy.

Jacobson JM, Felber BK, Chen H, Pavlakis GN, Mullins JI, De Rosa SC, Kuritzkes DR, Tomaras GD, Kinslow J, Bao Y, Olefsky M, Rosati M, Bear J, Heptinstall JR, Zhang L, Sawant S, Hannaman D, Laird GM, Cyktor JC, Heath SL, Collier AC, Koletar SL, Taiwo BO, Tebas P, Wohl DA, Belaunzaran-Zamudio PF, McElrath MJ, Landay AL; ACTG 5369 Study Team.

AIDS. 2024 Jun 1;38(7):963-973. doi: 10.1097/QAD.0000000000003804.

Cardiology Encounters for Underrepresented Racial and Ethnic Groups with Human Immunodeficiency Virus and Borderline Cardiovascular Disease Risk.

Bloomfield GS, Hill CL, Chiswell K, Cooper L, Gray S, Longenecker CT, Louzao D, Marsolo K, Meissner EG, Morse CG, Muiruri C, Thomas KL, Velazquez EJ, Vicini J, Pettit AC, Sanders G, Okeke NL.

J Racial Ethn Health Disparities. 2024 Jun;11(3):1509-1519. doi: 10.1007/s40615-023-01627-0.

The Climate Change Burden on Immune Health: Are Persons Living with HIV More at Risk?

Woolley G, Kroll K, Hoffman K, Ward A, Corneli A, Mudrak SV, Qureshi MU, Okeke NL, Chan C, Jones AD, Tomaras GD, Reeves RK.

AIDS Res Hum Retroviruses. 2024 May 27. doi: 10.1089/AID.2024.0050.

HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps.

Prakash P, Swami Vetha BS, Chakraborty R, Wenegieme TY, Masenga SK, Muthian G, Balasubramaniam M, Wanjalla CN, Hinton AO Jr, Kirabo A, Williams CR, Aileru A, Dash C.

Circ Res. 2024 May 24;134(11):e150-e175. doi: 10.1161/CIRCRESAHA.124.323979.

Understanding the Stigma Experience of Men Living with HIV in Sub-Saharan Africa: A Qualitative Meta-synthesis.

Janek SE, Hatoum S, Ledbetter L, Relf MV.

AIDS Behav. 2024 May 22. doi: 10.1007/s10461-024-04329-8.

Innate protection against intrarectal SIV acquisition by a live SHIV vaccine.

Sui Y, Meyer TJ, Fennessey CM, Keele BF, Dadkhah K, Ma C, LaBranche CC, Breed MW, Kramer JA, Li J, Howe SE, Ferrari G, Williams LD, Cam M, Kelly MC, Shen X, Tomaras GD, Montefiori D, Greten TF, Miller CJ, Berzofsky JA.

JCI Insight. 2024 May 21;9(12):e175800. doi: 10.1172/jci.insight.175800.

Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial.

Frank I, Li SS, Grunenberg N, Overton ET, Robinson ST, Zheng H, Seaton KE, Heptinstall JR, Allen MA, Mayer KH, Culver DA, Keefer MC, Edupuganti S, Pensiero MN, Mehra VL, De Rosa SC, Morris DE, Wang S, Seaman MS, Montefiori DC, Ferrari G, Tomaras GD, Kublin JG, Corey L, Lu S; HVTN 124 Study Team.

Lancet HIV. 2024 May;11(5):e285-e299. doi: 10.1016/S2352-3018(24)00036-5.

Intersectional climate justice, health equity, and HIV.

Wilson SM, Woolley G, Hawn C, Hoffman K, Jones AD, Chan C, Mudrak SV, Qureshi MU, Ward A, Knippler ET, Okeke NL, Corneli A, Tomaras GD, Reeves RK.

Lancet HIV. 2024 May;11(5):e280-e281. doi: 10.1016/S2352-3018(24)00062-6.

Intimate Partner Violence Among Rwandan Women With HIV: A Cross-Sectional Study.

Hatoum S, Mukamana D, Gishoma D, Kayiranga D, Pan W, Relf MV.

J Assoc Nurses AIDS Care. 2024 May-Jun 01;35(3):222-233. doi: 10.1097/JNC.0000000000000467.

Who is most vulnerable? Factors associated with presenting to antenatal care without a male partner in Northern Tanzania.

Sao SS, Coleman JN, Minja L, Mwamba RN, Kisigo GA, Osaki H, Renju J, Mmbaga BT, Watt MH.

Midwifery. 2024 May;132:103962. doi: 10.1016/j.midw.2024.103962.

Commensal bacteria inhibit viral infections via a tryptophan metabolite.

Jiang D, Soo N, Tan CY, Dankwa S, Wang HY, Theriot BS, Ardeshir A, Siddiqui NY, Van Rompay KKA, De Paris K, Permar SR, Goswami R, Surana NK.

bioRxiv [Preprint]. 2024 Apr 21:2024.04.21.589969. doi: 10.1101/2024.04.21.589969.

A profound absence of counseling interventions for suicide prevention among youth in Africa: A call to action based on an empty scoping review.

Knettel BA, Obale A, Iqbal H, Fotabong MC, Philippe NN, Graton M, Ledbetter L.

Suicide Life Threat Behav. 2024 Apr;54(2):296-301. doi: 10.1111/sltb.13041.

Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.

McKellar MS, Des Marais AC, Chen H, Choi Y, Lilly R, Ayers D, Bennett J, Kestner L, Perry B, Poley S, Corneli A, Meade CS, Sachdeva N.

Harm Reduct J. 2024 Mar 26;21(1):69. doi: 10.1186/s12954-024-00983-2.

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.

Moodie Z, Andersen-Nissen E, Grunenberg N, Dintwe OB, Omar FL, Kee JJ, Bekker LG, Laher F, Naicker N, Jani I, Mgodi NM, Hunidzarira P, Sebe M, Miner MD, Polakowski L, Ramirez S, Nebergall M, Takuva S, Sikhosana L, Heptinstall J, Seaton KE, De Rosa S, Diazgranados CA, Koutsoukos M, Van Der Meeren O, Barnett SW, Kanesa-Thasan N, Kublin JG, Tomaras GD, McElrath MJ, Corey L, Mngadi K, Goepfert P; HVTN 107 Protocol Team.

PLoS Med. 2024 Mar 19;21(3):e1004360. doi: 10.1371/journal.pmed.1004360.

Calcineurin contributes to RNAi-mediated transgene silencing and small interfering RNA production in the human fungal pathogen Cryptococcus neoformans.

Yadav V, Mohan R, Sun S, Heitman J.

Genetics. 2024 Mar 6;226(3):iyae010. doi: 10.1093/genetics/iyae010.

Nurse-Led Strategy to Improve Blood Pressure and Cholesterol Level Among People With HIV: A Randomized Clinical Trial.

Longenecker CT, Jones KA, Hileman CO, Okeke NL, Gripshover BM, Aifah A, Bloomfield GS, Muiruri C, Smith VA, Vedanthan R, Webel AR, Bosworth HB.

JAMA Netw Open. 2024 Mar 4;7(3):e2356445. doi: 10.1001/jamanetworkopen.2023.56445.

Diffuse myocardial fibrosis is uncommon in people with perinatally acquired human immunodeficiency virus infection.

Williams JL, Hung F, Jenista E, Barker P, Chakraborty H, Kim R, McCrary AW, Shah SH, Thielman N, Bloomfield GS.

AIDS Res Ther. 2024 Mar 4;21(1):13. doi: 10.1186/s12981-024-00598-4.

Identifying Implementation Strategies to Enhance HIV Pre-Exposure Prophylaxis Uptake Among Black Cisgender Women in New Orleans, Louisiana.

Clement ME, Perry B, McKenna K, Beckford J, Davenport T, Murray E, Magee V, Bickham JN, Siren J, Smith A, Lillis R, Corneli A.

AIDS Patient Care STDS. 2024 Mar;38(3):144-150. doi: 10.1089/apc.2023.0300.

Letter to the Editor: Cardiac Dysfunction Among Youth With Perinatal HIV Acquisition and Exposure.

McCrary AW, Hung F, Foster MC, Koech M, Nekesa J, Thielman N, Chakraborty H, Bloomfield GS, Nyandiko W.

J Acquir Immune Defic Syndr. 2024 Mar 1;95(3):e2-e4. doi: 10.1097/QAI.0000000000003353.

Understanding male involvement in antenatal care in the Kilimanjaro region of Tanzania: Barriers, facilitators, and opportunities for engagement.

Sao SS, Kisigo GA, Osaki H, Coleman JN, Renju J, Mwamba RN, Ngocho JS, Mmbaga BT, Watt MH.

Sex Reprod Healthc. 2024 Mar;39:100931. doi: 10.1016/j.srhc.2023.100931.

A Salon-Based Intervention to Improve PrEP Uptake among Black Women.

Randolph SD, Johnson R.

N Engl J Med. 2024 Feb 29;390(9):776-777. doi: 10.1056/NEJMp2313708. Epub 2024 Feb 24.

PMID: 38407253 No abstract available.

Through the looking glass: empowering youth community advisory boards in Tanzania as a sustainable youth engagement model to inform policy and practice.

Chow DWS, Goi A, Salm MF, Kupewa J, Mollel G, Mninda Y, Ambonisye J, Malongo A, Ketang'enyi E, Sanga E, Ngowi H, William R, Msuya E, Mmbaga BT, Mpili A, Dow DE.

Front Public Health. 2024 Feb 27;12:1348242. doi: 10.3389/fpubh.2024.1348242. eCollection 2024.

Tailoring Tfh profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques.

Verma A, Hawes CE, Elizaldi SR, Smith JC, Rajasundaram D, Pedersen GK, Shen X, Williams LD, Tomaras GD, Kozlowski PA, Amara RR, Iyer SS.

Elife. 2024 Feb 22;12:RP89395. doi: 10.7554/eLife.89395.

PMID: 38385642 Free PMC article.

Challenges and opportunities for improving mental health care and preventing suicide among people living with HIV: Perspectives of mental health professionals in Tanzania.

Knippler ET, Martinez AJ, Amiri I, Madundo K, Mmbaga BT, Goldston DB, Relf MV, Knettel BA.

PLOS Glob Public Health. 2024 Feb 16;4(2):e0002762. doi: 10.1371/journal.pgph.0002762.

Sexually Transmitted Infection Prevention Perspectives in Black Men Who Have Sex With Men Taking Preexposure Prophylaxis in New Orleans.

Clement ME, Beckford J, Lovett A, Siren J, Adorno M, Legrand S, Bennett M, Taylor J, Hanlen-Rosado E, Perry B, Corneli A.

Sex Transm Dis. 2024 Feb 1;51(2):90-95. doi: 10.1097/OLQ.0000000000001908.

Calcineurin contributes to RNAi-mediated transgene silencing and small interfering RNA production in the human fungal pathogen Cryptococcus neoformans.

Yadav V, Mohan R, Sun S, Heitman J.

bioRxiv [Preprint]. 2024 Jan 13:2023.07.25.550548. doi: 10.1101/2023.07.25.550548.

Update in: Genetics. 2024 Mar 6;226(3):iyae010. doi: 10.1093/genetics/iyae010.

Client Perspectives on the Development of a Rapid PrEP Initiative at a Sexual Health Center in New Orleans, Louisiana.

Lovett A, Luder R, Lillis RA, Butler I, Siren J, Gomez S, Kamis K, Obafemi O, Rowan SE, Baral S, Clement ME.

J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241258559. doi: 10.1177/23259582241258559.

PrEP-aring stylists: Development of a stylist educational workshop to increase PrEP awareness and knowledge among Black women in the US south .

Johnson R, Conley C, Jeter E, Randolph SD.

Public Health Nurs. 2024 Jan-Feb;41(1):57-66. doi: 10.1111/phn.13253. Epub 2023 Sep 18.

Patient and provider perspectives on barriers to myocardial infarction care among persons with human immunodeficiency virus in Tanzania: A qualitative study.

Prattipati S, Tarimo TG, Kweka GL, Mlangi JJ, Samuel D, Sakita FM, Tupetz A, Bettger JP, Thielman NM, Temu G, Hertz JT.

Int J STD AIDS. 2024 Jan;35(1):18-24. doi: 10.1177/09564624231199507. Epub 2023 Sep 13.

Don't see your paper listed? Make sure your publication is linked to the CFAR grant for funding. Visit the CFAR website for example text to use when acknowledging the CFAR and assistance by its Cores in your publications, abstracts, grant proposals, and presentations.

Have a new member of your team? Were you forwarded this newsletter and want to sign up yourself? Please use and share this link to join the CFAR and receive all CFAR information and news.